Patent · US Active

Cannula for minimizing dilution of dosing during nitric oxide delivery

US9550039B2 · kind B2 · utility

16Cited by
368References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 2014
Grant dateJan 24, 2017
Priority date
Expiry dateMar 1, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/0618
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (NO). As described herein, NO dilution can occur because of various factors. To reduce the dilution of an intended NO dose, various exemplary nasal cannulas, pneumatic configurations, methods of manufacturing, and methods of use, etc. are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.